Silidianin

Star0

DB20237ExperimentalSmall molecule

Silidianin is a small molecule drug. Silidianin has a monoisotopic molecular weight of 482.12 Da.

Mechanism: Pharmacologically active on P2Y purinoceptor 12, Tyrosinase, and Tyrosine-protein phosphatase non-receptor type 1
Curator reviewed
Formula / weight: C₂₅H₂₂O₁₀ · 482.441 g/mol (avg)

Resolves to

Compound

UNII7P89L7W179CAS29782-68-1

Structure

InChIKeyCYGIJEJDYJOUAN-MHZKHGHBSA-NSMILES[H][C@]12CO[C@@]3(O)C(=O)[C@H](C=C([C@H]4OC5=CC(O)=CC(O)=C5C(=O)[C@@H]4O)[C@@]13[H])[C@@H]2C1=CC=C(O)C(OC)=C1

Targets

Q9H244P2RY12P14679TYRP18031PTPN1

What you can answer from here — as of September 23, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Silidianin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account